Inhibition of glutathione biosynthesis alters compartmental redox status and the thiol proteome in organogenesis-stage rat conceptuses

Free Radical Biology and Medicine

Volumn 63, Issue , 2013, Pages 325-337

  Harris, Craig ^a   Shuster, Daniel Z ^a   Gomez, Rosaicela Roman ^a   Sant, Karilyn E ^a   Reed, Matthew S ^b   Pohl, Jan ^b   Hansen, Jason M ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Department of Pediatrics   (United States)

Author keywords

Amniotic fluid; Conceptus; Cysteine; Developmental signalling; Embryo; Glutathione; Organogenesis; Redox potential; Redox status; Spliceosome; Thiol proteome; Visceral yolk sac; Yolk sac fluid

Indexed keywords

AMINOACYL TRANSFER RNA; BUTHIONINE SULFOXIMINE; CYSTEINE; ENVIRONMENTAL CHEMICAL; GLUTATHIONE; HEAT SHOCK PROTEIN 70; IODOACETAMIDE; ISOTOPE; PROTEIN DISULFIDE ISOMERASE; PROTEOME;

AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BIOTINYLATION; CONCENTRATION (PARAMETERS); EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GLUTATHIONE METABOLISM; GLYCOLYSIS; MASS SPECTROMETRY; NONHUMAN; ORGANOGENESIS; OXIDATION; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN FOLDING; RAT; RNA PROCESSING; RNA STABILITY; STEADY STATE; YOLK SAC;

RATTUS;

EID: 84879492218     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.05.040     Document Type: Article

References (68)

1. Gu, Y. Z. The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40: 519-561; 2000.
2. Jones, D. P. Redox sensing: orthogonal control in cell cycle and apoptosis signalling. J. Intern. Med. 268: 432-448; 2010.
3. Burhans, W. C.; Heintz, N. H. The cell cycle is a redox cycle: linking phase-specific targets to cell fate. Free Radic. Biol. Med. 47: 1282-1293; 2009.
4. Hansen, J.M.; Harris, C. Redox control of teratogenesis. Reprod. Toxicol.
5. Hansen, J. M. Thalidomide modulates nuclear redox status and preferentially depletes glutathione in rabbit limb versus rat limb. J. Pharmacol. Exp. Ther 300: 768-776; 2002. (Pubitemid 34164978)
6. Hansen, J. M. A novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway. Antioxid. Redox Signal 6: 1-14; 2004. (Pubitemid 38063971)
7. Gius, D. Redox signaling in cancer biology. Antioxid. Redox Signal. 8: 1249-1252; 2006. (Pubitemid 44182423)
8. Gupta, S. C. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid. Redox Signal 16: 1295-1322; 2012.
9. Butterfield, D. A. Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid. Redox Signal 120118110231009; 2012.
10. Sabens Liedhegner, E. A. Mechanisms of altered redox regulation in neurode-generative diseases-focus on S-glutathionylation. Antioxid. Redox Signal 16: 543-566; 2012.
11. Delmastro, M. M.; Piganelli, J. D. Oxidative stress and redox modulation potential in type 1 diabetes. Clin. Dev. Immunol. 2011; 2011.
12. Tavakoli, S. Reactive oxygen species and thiol redox signaling in the macro-phage biology of atherosclerosis. Antioxid. Redox Signal 120611124142004; 2012.
13. Turan, B. Role of antioxidants in redox regulation of diabetic cardiovascular complications. Curr. Pharm. Biotechnol. 11 : 819-836; 2010.
14. Go, Y.-M. Cysteine/cystine redox signaling in cardiovascular disease. Free Radic. Biol. Med. 50: 495-509; 2011.
15. Charles, R. L. Redox signalling in cardiovascular disease. Proteomics Clin. Appl. 2: 823-836; 2008. (Pubitemid 351943764)
16. Hansen, J. M. Oxidative stress as a mechanism of teratogenesis. Birth Defects Res. C Embryo Today 78: 293-307; 2006. (Pubitemid 46365293)
17. Finkel, T. Signal transduction by reactive oxygen species. J. Cell Biol. 194: 7-15; 2011.
18. Ray, P. D. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal 24: 981-990; 2012.
19. Zhang, Y. Redox control of the survival of healthy and diseased cells. Antioxid. Redox Signal 15: 2867-2908; 2011.
20. Valko, M. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol 39: 44-84; 2007. (Pubitemid 44566469)
21. Dennery, P. A. Effects of oxidative stress on embryonic development. Birth Defects Res. C Embryo Today 81: 155-162; 2007. (Pubitemid 350086244)
22. Hansen, J. M.; Watson, W. H.; Jones, D. P. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol. Sci. 82: 308-317; 2004. (Pubitemid 39485343)
23. Kamata, T.; Ambo, H.; Puzon-McLaughlin, W.; Tieu, K. K.; Handa, M.; Ikeda, Y.; Takada, Y. Critical cysteine residues for regulation of integrin alpha IIb beta 3 are clustered in the epidermal growth factor domains of the beta 3 subunit. Portland Press; 2004.
24. Stanic, B.; Katsuyama, M.; Miller, F. J. An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation. Arter-ioscler. Thromb. Vasc. Biol 30: 2234-2241; 2010.
25. Gius, D.; Botero, A.; Shah, S.; Curry, H. A. Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1. Toxicol. Lett. 106: 93-106; 1999. (Pubitemid 29257819)
26. Harris, C.; Fantel, A. G.; Juchau, M. R. Differential glutathione depletion by l-buthionine-S, R-sulfoximine in rat embryo versus visceral yolk sac in vivo and in vitro. Biochem. Pharmacol 35: 4437-4441; 1986. (Pubitemid 17223275)
27. Harris, C.; Dixon, M.; Hansen, J. M. Glutathione depletion modulates methanol, formaldehyde and formate toxicity in cultured rat conceptuses. Cell Biol. Toxicol. 20: 133-145; 2004. (Pubitemid 38988050)
28. Harris, C. Rodent whole embryo culture. Methods Mol. Biol. 889: 215-237; 2012.
29. Jones, D. P. Redox potential of GSH/GSSG couple: assay and biological significance. In: Helmut, S., Lester, P., editors. Methods in enzymology. Academic Press; 2002. p. 93-112 . (Pubitemid 41103102)
30. Harris, C. Oxidative stress, thiols, and redox profiles. Methods Mol. Biol. 889: 325-346; 2012.
31. Kirlin, W. G. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic. Biol. Med. 27: 1208-1218; 1999. (Pubitemid 30001481)
32. Hansen, J. M.; Moriarty-Craige, S.; Jones, D. P. Nuclear and cytoplasmic peroxiredoxin-1 differentially regulate NF-κB activities. Free Radic. Biol. Med. 43: 282-288; 2007. (Pubitemid 46977170)
33. Fu, C.; Hu, J.; Liu, T.; Ago, T.; Sadoshima, J.; Li, H. Quantitative analysis of redox-sensitive proteome with DIGE and ICAT. J. Proteome Res. 7: 3789-3802; 2008.
34. Go, Y.-M. Quantification of redox conditions in the nucleus. Methods Mol. Biol. 464: 303-317; 2009.
35. Rowe, P. B. Serine metabolism in rat embryos undergoing organogenesis. J. Embryol. Exp. Morphol 87: 137-144; 1985. (Pubitemid 15029932)
36. Chartoumpekis, D. V.; Ziros, P. G.; Psyrogiannis, A. I.; Papavassiliou, A. G.; Kyriazopoulou, V. E.; Sykiotis, G. P.; Habeos, I. G. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes 60: 2465-2473; 2011.
37. Harris, C. Hypoxia and altered redox status in embryotoxicity. In: Kavlock, R., Daston, G., editors. Drug toxicity in embryonic development I. Berlin Heidelberg: Springer; 1997. p. 519-548.
38. Nkabyo, Y. S. Thiol/disulfide redox status is oxidized in plasma and small intestinal and colonic mucosa of rats with inadequate sulfur amino acid intake. J. Nutr 136: 1242-1248; 2006.
39. Iyer, S. S.; Accardi, C. J.; Ziegler, T. R.; Blanco, R. A.; Ritzenthaler, J. D.; Rojas, M.; Roman, J.; Jones, D. P. Cysteine redox potential determines pro-inflammatory il-1ß levels. PloS ONE 4:e5017; 2009.
40. Moriarty-Craige, S. E. Extracellular thiols and thiol/disulfide redox in metabolism. Annu. Rev. Nutr. 24: 481-509; 2004. (Pubitemid 38938801)
41. Harris, C.; Hiranruengchok, R.; Lee, E.; Berberian, R. M.; Eurich, G. E. Glutathione status in chemical embryotoxicity: synthesis, turnover and adduct formation. Toxicol. In Vitro 9: 623-631; 1995.
42. Hansen, J. M.; Lee, E.; Harris, C. Spatial activities and induction of glutamate-cysteine ligase (GCL) in the postimplantation rat embryo and visceral yolk sac. Toxicol. Sci 81: 371-378; 2004. (Pubitemid 39377967)
43. Harris, C. Glutathione biosynthesis in the postimplantation rat conceptus in vitro. toxicol. Appl. Pharmacol. 120: 247-256; 1993. (Pubitemid 23203329)
44. Ottaviano, F. G. Redox regulation in the extracellular environment. Circ. J. 72: 1-16; 20 08. (Pubitemid 351413319)
45. Brent, R. L.; Beckman, D. A.; Jensen, M.; Koszalka, T. R. Experimental yolk sac dysfunction as a model for studying nutritional disturbances in the embryo during early organogenesis. Teratology 41: 405-413; 1990. (Pubitemid 20110440)
46. Brent, R. L. Experimental yolk sac dysfunction as a model for studying nutritional disturbances in the embryo during early organogenesis. Teratology (Philadelphia) 41: 405-413; 1990. (Pubitemid 20110440)
47. Burton, G. J. Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J. Clin. Endocrinol. Metab 87: 2954-2959; 2002. (Pubitemid 34655369)
48. Hanigan, M. H.; Ricketts, W. A. Extracellular glutathione is a source of cysteine for cells that express.gamma.-glutamyl transpeptidase. Biochemistry 32: 6302-6306; 1993. (Pubitemid 23196889)
49. Hutter, D. E.; Till, B. G.; Greene, J. J. Redox state changes in density-dependent regulation of proliferation. Exp. Cell Res. 232: 435-438; 1997. (Pubitemid 27194060)
50. Sen, C. K. Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720; 1996. (Pubitemid 26172817)
51. Sun, Y.; Oberley, L. W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21: 335-348; 1996. (Pubitemid 26271723)
52. Harris, C.; Hansen, J. M. Nrf2-mediated resistance to oxidant-induced redox disruption in embryos. Birth Defects Res. B Dev. Reprod. Toxicol. 95: 213-218; 2012.
53. Ozolinš, T. R. S. Regulation and control of AP-1 binding activity in embry-otoxicity. Methods Mol. Biol. 889: 291-303; 2012.
54. Bae, Y. S.; Kang, S. W.; Seo, M. S.; Baines, I. C.; Tekle, E.; Chock, P. B.; Rhee, S. G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. J. Biol. Chem. 272: 217-221; 1997.
55. Acharya, A. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxidative Med. Cell. Longevity 3: 23-34; 2010.
56. Giles, G. I. The redox regulation of thiol dependent signaling pathways in cancer. Curr. Pharm. Des 12: 4427-4443; 2006. (Pubitemid 44835155)
57. Chen, M.; Manley, J. L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell. Biol. 10: 741 -754; 2009.
58. Revil, T.; Gaffney, D.; Dias, C.; Majewski, J.; Jerome-Majewska, L. Alternative splicing is frequent during early embryonic development in mouse. BMC Genomics 11 : 399; 2010.
59. Guo, Q.; Li, J. Y. H. Distinct functions of the major Fgf8 spliceform, Fgf8b, before and during mouse gastrulation. Development 134: 2251-2260; 2007. (Pubitemid 47010014)
60. Guo, Q.; Li, K.; Sunmonu, N. A.; Li, J. Y. H. Fgf8b-containing spliceforms, but not Fgf8a, are essential for Fgf8 function during development of the midbrain and cerebellum. Dev. Biol. 338: 18 3 -192; 2010.
61. Fletcher, R. B.; Baker, J. C.; Harland, R. M. FGF8 spliceforms mediate early mesoderm and posterior neural tissue formation in Xenopus. Development 133: 1703-1714 ; 2 0 0 6 . (Pubitemid 43810977)
62. Ghosh, A. K. Molecular cloning and characterization of human FGF8 alternative messenger RNA forms. Cell Growth Differ 7: 1425-1434; 1996. (Pubitemid 26360691)
63. MacArthur, C. A. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ 6: 817-825; 1995.
64. Reyes-Hernández, O. D.; Mejía-García, A.; Sánchez-Ocampo, E. M.; Castro-Muñozledo, F.; Hernández- Muñoz, R.; Elizondo, G. Aromatic hydrocarbons upregulate glyceraldehyde-3-phosphate dehydrogenase and induce changes in actin cytoskeleton. Role of the aryl hydrocarbon receptor (AhR). Toxicology 266: 30-37; 2009.
65. Higashimura, Y.; Nakajima, Y.; Yamaji, R.; Harada, N.; Shibasaki, F.; Nakano, Y.; Inui, H. Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells. Arch. Biochem. Biophys. 509: 1-8; 2011.
66. Rodríguez-Pascual, F. Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability. Mol. Cell. Biol 28: 7139-7155; 2008.
67. Kalmar Greensmith, B. L. Induction of heat shock proteins for protection against oxidative stress. Adv. Drug Deliv. Rev. 61: 310-318; 2009.
68. Ling, J. Severe oxidative stress induces protein mistranslation through impairment of an aminoacyl-tRNA synthetase editing site. Proc. Natl. Acad. Sci. USA 107: 4028-4033; 2010.)